NR4A orphan nuclear receptors in glucose homeostasis: A minireview

Diabetes and Metabolism

Volumn 39, Issue 6, 2013, Pages 478-484

  Close, A F ^a   Rouillard, C ^b   Buteau, J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Diabetes; Glucose; Insulin; Metabolism; NR4A; Nuclear receptor; Transcription factor

Indexed keywords

DNA; GLUCOSE; NR4A ORPHAN NUCLEAR RECEPTOR; ORPHAN NUCLEAR RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA BINDING; ENERGY EXPENDITURE; FATTY ACID METABOLISM; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGANOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

DIABETES; DIABÈTE; FACTEUR DE TRANSCRIPTION; GLUCOSE; INSULIN; INSULINE; METABOLISM; MÉTABOLISME; NR4A; NUCLEAR RECEPTOR; RÉCEPTEUR NUCLÉAIRE; TRANSCRIPTION FACTOR;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1;

EID: 84887626512     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.07.005     Document Type: Review

References (81)

1. Committee N.R.N. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999, 97:161-163.
2. Saucedo-Cardenas O., Kardon R., Ediger T.R., Lydon J.P., Conneely O.M. Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor NURR1. Gene 1997, 187:135-139.
3. Castro D.S., Arvidsson M., Bondesson Bolin M., Perlmann T. Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2. J Biol Chem 1999, 274:37483-37490.
4. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 2003, 423:555-560.
5. Volakakis N., Malewicz M., Kadkhodai B., Perlmann T., Benoit G. Characterization of the Nurr1 ligand-binding domain co-activator interaction surface. J Mol Endocrinol 2006, 37:317-326.
6. Han Y.H., Cao X., Lin B., Lin F., Kolluri S.K., Stebbins J., et al. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene 2006, 25:2974-2986.
7. Wingate A.D., Campbell D.G., Peggie M., Arthur J.S. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem J 2006, 393:715-724.
8. Kovalovsky D., Refojo D., Liberman A.C., Hochbaum D., Pereda M.P., Coso O.A., et al. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 2002, 16:1638-1651.
9. Galleguillos D., Vecchiola A., Fuentealba J.A., Ojeda V., Alvarez K., Gomez A., et al. PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J Biol Chem 2004, 279:2005-2011.
10. Arredondo C., Orellana M., Vecchiola A., Pereira L.A., Galdames L., Andres M.E. PIASgamma Enhanced SUMO-2 Modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy. PLoS One 2013, 8:e55035.
11. Wilson T.E., Fahrner T.J., Johnston M., Milbrandt J. Identification of the DNA-binding site for NGFI-B by genetic selection in yeast. Science 1991, 252:1296-1300.
12. Wilson T.E., Fahrner T.J., Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 1993, 13:5794-5804.
13. Maira M., Martens C., Philips A., Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol 1999, 19:7549-7557.
14. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995, 81:541-550.
15. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995, 9:769-782.
16. Lammi J., Aarnisalo P. FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts. Mol Cell Endocrinol 2008, 295:87-93.
17. Maxwell M.A., Cleasby M.E., Harding A., Stark A., Cooney G.J., Muscat G.E. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 2005, 280:12573-12584.
18. Heard M., Maina C.V., Morehead B.E., Hoener M.C., Nguyen T.Q., Williams C.C., et al. A functional NR4A nuclear receptor DNA-binding domain is required for organ development in Caenorhabditis elegans. Genesis 2010, 48:485-491.
19. Gissendanner C.R., Kelley K., Nguyen T.Q., Hoener M.C., Sluder A.E., Maina C.V. The Caenorhabditis elegans NR4A nuclear receptor is required for spermatheca morphogenesis. Dev Biol 2008, 313:767-786.
20. Gizard F., Zhao Y., Findeisen H.M., Qing H., Cohn D., Heywood E.B., et al. Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells. J Biol Chem 2011, 286:35485-35493.
21. Hawk J.D., Bookout A.L., Poplawski S.G., Bridi M., Rao A.J., Sulewski M.E., et al. NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J Clin Invest 2012, 122:3593-3602.
22. Sekiya T., Kashiwagi I., Yoshida R., Fukaya T., Morita R., Kimura A., et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 2013, 14:230-237.
23. McNulty S.E., Barrett R.M., Vogel-Ciernia A., Malvaez M., Hernandez N., Davatolhagh M.F., et al. Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. Learn Mem 2012, 19:588-592.
24. Woronicz J.D., Calnan B., Ngo V., Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994, 367:277-281.
25. Tao R., Hancock W.W. Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survival. PLoS One 2008, 3:e2321.
26. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-250.
27. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 1998, 95:4013-4018.
28. Kadkhodaei B., Ito T., Joodmardi E., Mattsson B., Rouillard C., Carta M., et al. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 2009, 29:15923-15932.
29. St-Hilaire M., Bourhis E., Levesque D., Rouillard C. Impaired behavioural and molecular adaptations to dopamine denervation and repeated l-DOPA treatment in Nur77-knockout mice. Eur J Neurosci 2006, 24:795-805.
30. Bonta P.I., van Tiel C.M., Vos M., Pols T.W., van Thienen J.V., Ferreira V., et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006, 26:2288-2294.
31. Zhao Y., Bruemmer D. NR4A orphan nuclear receptors in cardiovascular biology. Drug Discov Today Dis Mech 2009, 6:e43-e48.
32. Arkenbout E.K., de Waard V., van Bragt M., van Achterberg T.A., Grimbergen J.M., Pichon B., et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002, 106:1530-1535.
33. Mohan H.M., Aherne C.M., Rogers A.C., Baird A.W., Winter D.C., Murphy E.P. Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res 2012, 18:3223-3228.
34. Smith A.G., Lim W., Pearen M., Muscat G.E., Sturm R.A. Regulation of NR4A nuclear receptor expression by oncogenic BRAF in melanoma cells. Pigment Cell Melanoma Res 2011, 24:551-563.
35. McMorrow J.P., Murphy E.P. Inflammation: a role for NR4A orphan nuclear receptors?. Biochem Soc Trans 2011, 39:688-693.
36. Pei L., Castrillo A., Chen M., Hoffmann A., Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 2005, 280:29256-29262.
37. Mix K.S., McMahon K., McMorrow J.P., Walkenhorst D.E., Smyth A.M., Petrella B.L., et al. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription. Arthritis Rheum 2012, 64:2126-2136.
38. O'Kane M., Markham T., McEvoy A.N., Fearon U., Veale D.J., FitzGerald O., et al. Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition. J Invest Dermatol 2008, 128:300-310.
39. Pei L., Waki H., Vaitheesvaran B., Wilpitz D.C., Kurland I.J., Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006, 12:1048-1055.
40. Fu Y., Luo L., Luo N., Zhu X., Garvey W.T. NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 2007, 282:31525-31533.
41. Kanzleiter T., Wilks D., Preston E., Ye J., Frangioudakis G., Cooney G.J. Regulation of the nuclear hormone receptor nur77 in muscle: influence of exercise-activated pathways in vitro and obesity in vivo. Biochim Biophys Acta 2009, 1792:777-782.
42. Veum V.L., Dankel S.N., Gjerde J., Nielsen H.J., Solsvik M.H., Haugen C., et al. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. Int J Obes (Lond) 2012, 36:1195-1202.
43. Briand O., Helleboid-Chapman A., Ploton M., Hennuyer N., Carpentier R., Pattou F., et al. The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic beta-cells. Mol Endocrinol 2012, 26:399-413.
44. Navarro M.A., Badimon L., Rodriguez C., Arnal C., Noone E.J., Roche H.M., et al. Trans-10,cis-12-CLA dysregulate lipid and glucose metabolism and induce hepatic NR4A receptors. Front Biosci (Elite Ed) 2010, 2:87-97.
45. Roche E., Buteau J., Aniento I., Reig J.A., Soria B., Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 1999, 48:2007-2014.
46. Zhang L., Paine C., Dip R. Selective regulation of nuclear orphan receptors 4A by adenosine receptor subtypes in human mast cells. J Cell Commun Signal 2010, 4:173-183.
47. Mahoney D.J., Parise G., Melov S., Safdar A., Tarnopolsky M.A. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 2005, 19:1498-1500.
48. Catoire M., Mensink M., Boekschoten M.V., Hangelbroek R., Muller M., Schrauwen P., et al. Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS One 2012, 7:e51066.
49. Kawasaki E., Hokari F., Sasaki M., Sakai A., Koshinaka K., Kawanaka K. Role of local muscle contractile activity in the exercise-induced increase in NR4A receptor mRNA expression. J Appl Physiol 2009, 106:1826-1831.
50. Rhodes C.J. Type 2 diabetes-a matter of beta-cell life and death?. Science 2005, 307:380-384.
51. Susini S., Roche E., Prentki M., Schlegel W. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells. FASEB J 1998, 12:1173-1182.
52. Wu X., Wang J., Cui X., Maianu L., Rhees B., Rosinski J., et al. The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle. Endocrine 2007, 31:5-17.
53. Rome S., Clement K., Rabasa-Lhoret R., Loizon E., Poitou C., Barsh G.S., et al. Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem 2003, 278:18063-18068.
54. Chao L.C., Zhang Z., Pei L., Saito T., Tontonoz P., Pilch P.F. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol Endocrinol 2007, 21:2152-2163.
55. Chao L.C., Wroblewski K., Zhang Z., Pei L., Vergnes L., Ilkayeva O.R., et al. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 2009, 58:2788-2796.
56. Chao L.C., Wroblewski K., Ilkayeva O.R., Stevens R.D., Bain J., Meyer G.A., et al. Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J Lipid Res 2012, 53:2610-2619.
57. Pearen M.A., Eriksson N.A., Fitzsimmons R.L., Goode J.M., Martel N., Andrikopoulos S., et al. The nuclear receptor. Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue. Mol Endocrinol 2012, 26:372-384.
58. Zhu X., Walton R.G., Tian L., Luo N., Ho S.R., Fu Y., et al. Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3. Horm Metab Res 2012, 45:213-220.
59. Wang S.C., Myers S.A., Eriksson N.A., Fitzsimmons R.L., Muscat G.E. Nr4a1 siRNA expression attenuates alpha-MSH regulated gene expression in 3T3-L1 adipocytes. Mol Endocrinol 2011, 25:291-306.
60. DeFronzo R.A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 1992, 35:389-397.
61. Valera A., Pujol A., Pelegrin M., Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1994, 91:9151-9154.
62. Berriel Diaz M., Lemke U., Herzig S. Discovering orphans' sweet secret: NR4A receptors and hepatic glucose production. Cell Metab 2006, 4:339-340.
63. Manco M., Mingrone G., Greco A.V., Capristo E., Gniuli D., De Gaetano A., et al. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 2000, 49:220-224.
64. Sinha R., Dufour S., Petersen K.F., LeBon V., Enoksson S., Ma Y.Z., et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002, 51:1022-1027.
65. Kumashiro N., Erion D.M., Zhang D., Kahn M., Beddow S.A., Chu X., et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 2011, 108:16381-16385.
66. Bergman B.C., Hunerdosse D.M., Kerege A., Playdon M.C., Perreault L. Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia 2012, 55:1140-1150.
67. Perez-Sieira S., Martinez G., Porteiro B., Lopez M., Vidal A., Nogueiras R., et al. Female nur77-deficient mice show increased susceptibility to diet-induced obesity. PLoS One 2013, 8:e53836.
68. Pols T.W., Ottenhoff R., Vos M., Levels J.H., Quax P.H., Meijers J.C., et al. Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 2008, 366:910-916.
69. Eaton S., Bartlett K., Quant P.A. Carnitine palmitoyl transferase I and the control of beta-oxidation in heart mitochondria. Biochem Biophys Res Commun 2001, 285:537-539.
70. Fritz I.B., Schultz S.K., Srere P.A. Properties of partially purified carnitine acetyltransferase. J Biol Chem 1963, 238:2509-2517.
71. Bruce C.R., Hoy A.J., Turner N., Watt M.J., Allen T.L., Carpenter K., et al. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009, 58:550-558.
72. Gao X.F., Chen W., Kong X.P., Xu A.M., Wang Z.G., Sweeney G., et al. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake. Diabetologia 2009, 52:912-920.
73. Ishizawa M., Kagechika H., Makishima M. NR4A nuclear receptors mediate carnitine palmitoyltransferase 1A gene expression by the rexinoid HX600. Biochem Biophys Res Commun 2012, 418:780-785.
74. Rutter G.A. Think zinc: new roles for zinc in the control of insulin secretion. Islets 2010, 2:49-50.
75. Weyrich P., Staiger H., Stancakova A., Schafer S.A., Kirchhoff K., Ullrich S., et al. Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects. BMC Med Genet 2009, 10:77.
76. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
77. Xiao Q., Castillo S.O., Nikodem V.M. Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 1996, 75:221-230.
78. Murphy E.P., Conneely O.M. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 1997, 11:39-47.
79. Nonogaki K., Kaji T., Ohba Y., Sumii M., Wakameda M., Tamari T. Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice. Biochem Biophys Res Commun 2009, 386:311-315.
80. Sutherland J.D., Kozlova T., Tzertzinis G., Kafatos F.C. Drosophila hormone receptor 38: a second partner for Drosophila USP suggests an unexpected role for nuclear receptors of the nerve growth factor-induced protein B type. Proc Natl Acad Sci U S A 1995, 92:7966-7970.
81. Ruaud A.F., Lam G., Thummel C.S. The Drosophila NR4A nuclear receptor DHR38 regulates carbohydrate metabolism and glycogen storage. Mol Endocrinol 2011, 25:83-91.